Granted Patent B2

US 12,698,270 · App. 18/255,247 · Granted Aug 4, 2026

Inventors: Long Zhang (Hangzhou, CN); Zhangming Niu (Hangzhou, CN); Bowen Tang (Hangzhou, CN)

Assignee: MINDRANK AI LTD.

C07D401/14C07D405/14C07D471/04

Abstract

Claims (10)

1 . A compound, which is:

or a pharmaceutically acceptable salt, solvate, enantiomer, or isotopic variation thereof.

2 . The compound of claim 1 , which is:

or a pharmaceutically acceptable salt thereof.

3 . The compound of claim 1 , which is:

or a pharmaceutically acceptable salt.

4 . The compound of claim 1 , which is:

or a pharmaceutically acceptable salt.

5 . A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 1 .

6 . A method of treating obesity or diabetes in a subject in need thereof, comprising administering a therapeutically effective amount of the compound of claim 1 to the subject.

Assignments (1)

Priority Claims (2)

Continuity (1)

References Cited (70)